Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 238

1.

A population pharmacokinetic model to predict the individual starting dose of tacrolimus in adult renal transplant recipients.

Andrews LM, Hesselink DA, van Schaik RHN, van Gelder T, de Fijter JW, Lloberas N, Elens L, Moes DJAR, de Winter BCM.

Br J Clin Pharmacol. 2018 Dec 14. doi: 10.1111/bcp.13838. [Epub ahead of print]

PMID:
30552703
2.

Effect of Lanreotide on Kidney Function in Patients With Autosomal Dominant Polycystic Kidney Disease: The DIPAK 1 Randomized Clinical Trial.

Meijer E, Visser FW, van Aerts RMM, Blijdorp CJ, Casteleijn NF, D'Agnolo HMA, Dekker SEI, Drenth JPH, de Fijter JW, van Gastel MDA, Gevers TJ, Lantinga MA, Losekoot M, Messchendorp AL, Neijenhuis MK, Pena MJ, Peters DJM, Salih M, Soonawala D, Spithoven EM, Wetzels JF, Zietse R, Gansevoort RT; DIPAK-1 Investigators.

JAMA. 2018 Nov 20;320(19):2010-2019. doi: 10.1001/jama.2018.15870.

PMID:
30422235
3.

Low wintertime pre-diagnostic vitamin D status is associated with an increased risk of internal malignancies in kidney transplant recipients.

de Gruijl FR, Wolterbeek R, Pavel S, de Fijter JW, Hamdy NAT, Bouwes Bavinck JN.

Photochem Photobiol Sci. 2018 Dec 5;17(12):1946-1955. doi: 10.1039/c7pp00404d.

PMID:
30397693
4.

Erratum.

Kers J, Peters-Sengers H, Heemskerk MBA, Berger SP, Betjes MGH, van Zuilen AD, Hilbrands LB, de Fijter JW, Nurmohamed AS, Christiaans MH, Homan van der Heide JJ, Debray TPA, Bemelman FJ.

Nephrol Dial Transplant. 2018 Oct 29. doi: 10.1093/ndt/gfy353. [Epub ahead of print] No abstract available.

PMID:
30376111
5.

A paired kidney analysis on the impact of pre-transplant anti-HLA antibodies on graft survival.

Michielsen LA, Wisse BW, Kamburova EG, Verhaar MC, Joosten I, Allebes WA, van der Meer A, Hilbrands LB, Baas MC, Spierings E, Hack CE, van Reekum FE, Bots ML, Drop ACAD, Plaisier L, Seelen MAJ, Sanders JF, Hepkema BG, Lambeck AJ, Bungener LB, Roozendaal C, Tilanus MGJ, Voorter CE, Wieten L, van Duijnhoven EM, Gelens M, Christiaans MHL, van Ittersum FJ, Nurmohamed SA, Lardy NM, Swelsen W, van der Pant KA, van der Weerd NC, Ten Berge IJM, Bemelman FJ, Hoitsma A, van der Boog PJM, de Fijter JW, Betjes MGH, Heidt S, Roelen DL, Claas FH, Otten HG, van Zuilen AD.

Nephrol Dial Transplant. 2018 Oct 25. doi: 10.1093/ndt/gfy316. [Epub ahead of print]

PMID:
30365008
6.

Urinary TIMP-2 predicts the presence and duration of delayed graft function in donation after circulatory death kidney transplant recipients.

Bank JR, Ruhaak R, Soonawala D, Mayboroda O, Romijn FP, van Kooten C, Cobbaert CM, de Fijter JW.

Transplantation. 2018 Oct 8. doi: 10.1097/TP.0000000000002472. [Epub ahead of print]

PMID:
30300282
7.

Therapeutic drug monitoring of tacrolimus and mycophenolic acid in outpatient renal transplant recipients using a volumetric dried blood spot sampling device.

Zwart TC, Gokoel SRM, van der Boog PJM, de Fijter JW, Kweekel DM, Swen JJ, Guchelaar HJ, Moes DJAR.

Br J Clin Pharmacol. 2018 Dec;84(12):2889-2902. doi: 10.1111/bcp.13755. Epub 2018 Oct 15.

PMID:
30176064
8.

Early Steroid Withdrawal Compared With Standard Immunosuppression in Kidney Transplantation - Interim Analysis of the Amsterdam-Leiden-Groningen Randomized Controlled Trial.

van Sandwijk MS, de Vries APJ, Bakker SJL, Ten Berge IJM, Berger SP, Bouatou YR, de Fijter JW, Florquin S, Homan van der Heide JJ, Idu MM, Krikke C, van der Pant KAMI, Reinders ME, Ringers J, van der Weerd NC, Bemelman FJ, Sanders JS.

Transplant Direct. 2018 May 15;4(6):e354. doi: 10.1097/TXD.0000000000000794. eCollection 2018 Jun.

9.

Toward a sensible single antigen bead cut-off based on kidney graft survival.

Wisse BW, Kamburova EG, Joosten I, Allebes WA, van der Meer A, Hilbrands LB, Baas MC, Spierings E, Hack CE, van Reekum FE, van Zuilen AD, Verhaar MC, Bots ML, Drop ACAD, Plaisier L, Seelen MAJ, Sanders JS, Hepkema BG, Lambeck AJA, Bungener LB, Roozendaal C, Tilanus MGJ, Voorter CE, Wieten L, van Duijnhoven EM, Gelens MACJ, Christiaans MHL, van Ittersum FJ, Nurmohamed SA, Lardy JNM, Swelsen W, van der Pant KAMI, van der Weerd NC, Ten Berge IJM, Bemelman FJ, Hoitsma AJ, van der Boog PJM, de Fijter JW, Betjes MGH, Heidt S, Roelen DL, Claas FH, Otten HG.

Transplantation. 2018 Aug 13. doi: 10.1097/TP.0000000000002357. [Epub ahead of print]

PMID:
30106794
10.

Pretransplant C3d-Fixing Donor-Specific Anti-HLA Antibodies Are Not Associated with Increased Risk for Kidney Graft Failure.

Kamburova EG, Wisse BW, Joosten I, Allebes WA, van der Meer A, Hilbrands LB, Baas MC, Spierings E, Hack CE, van Reekum FE, van Zuilen AD, Verhaar MC, Bots ML, Drop ACAD, Plaisier L, Seelen MAJ, Sanders JS, Hepkema BG, Lambeck AJA, Bungener LB, Roozendaal C, Tilanus MGJ, Voorter CE, Wieten L, van Duijnhoven EM, Gelens MACJ, Christiaans MHL, van Ittersum FJ, Nurmohamed SA, Lardy NM, Swelsen W, van der Pant KAMI, van der Weerd NC, Ten Berge IJM, Bemelman FJ, Hoitsma AJ, van der Boog PJM, de Fijter JW, Betjes MGH, Heidt S, Roelen DL, Claas FH, Otten HG.

J Am Soc Nephrol. 2018 Sep;29(9):2279-2285. doi: 10.1681/ASN.2018020205. Epub 2018 Jul 26.

PMID:
30049681
11.

Reduced Risk of BK Polyomavirus Infection in HLA-B51 Positive Kidney Transplant Recipients.

Wunderink HF, Haasnoot GW, de Brouwer CS, van Zwet EW, Kroes ACM, de Fijter JW, Rotmans JI, Claas FHJ, Feltkamp MCW.

Transplantation. 2018 Jul 25. doi: 10.1097/TP.0000000000002376. [Epub ahead of print]

PMID:
30048396
12.

Clinical predictors of escalating care in hepatic and renal cyst infection in autosomal dominant polycystic kidney and liver disease.

Lantinga MA, de SĂ©vaux RGL, Gevers TJG, Oyen WJG, de Fijter JW, Soonawala D, Zietse R, Salih M, Casteleijn NF, Spithoven EM, Meijer E, Gansevoort RT, Drenth On Behalf Of The Dipak Consortium JPH.

Neth J Med. 2018 Jul;76(5):226-234.

13.

Cardiovascular Risk Factors Accelerate Kidney Function Decline in Post-Myocardial Infarction Patients: The Alpha Omega Cohort Study.

Esmeijer K, Geleijnse JM, de Fijter JW, Giltay EJ, Kromhout D, Hoogeveen EK.

Kidney Int Rep. 2018 Mar 16;3(4):879-888. doi: 10.1016/j.ekir.2018.03.005. eCollection 2018 Jul.

14.

Urinary metabolites predict prolonged duration of delayed graft function in DCD kidney transplant recipients.

Kostidis S, Bank JR, Soonawala D, Nevedomskaya E, van Kooten C, Mayboroda OA, de Fijter JW.

Am J Transplant. 2018 May 22. doi: 10.1111/ajt.14941. [Epub ahead of print]

PMID:
29786954
15.

Everolimus with Reduced Calcineurin Inhibitor Exposure in Renal Transplantation.

Pascual J, Berger SP, Witzke O, Tedesco H, Mulgaonkar S, Qazi Y, Chadban S, Oppenheimer F, Sommerer C, Oberbauer R, Watarai Y, Legendre C, Citterio F, Henry M, Srinivas TR, Luo WL, Marti A, Bernhardt P, Vincenti F; TRANSFORM Investigators.

J Am Soc Nephrol. 2018 Jul;29(7):1979-1991. doi: 10.1681/ASN.2018010009. Epub 2018 May 11.

PMID:
29752413
16.

A pharmacological rationale for improved everolimus dosing in oncology and transplant patients.

Ter Heine R, van Erp NP, Guchelaar HJ, de Fijter JW, Reinders MEJ, van Herpen CM, Burger DM, Moes DJAR.

Br J Clin Pharmacol. 2018 Jul;84(7):1575-1586. doi: 10.1111/bcp.13591. Epub 2018 May 6.

PMID:
29574974
17.

PIRCHE-II Is Related to Graft Failure after Kidney Transplantation.

Geneugelijk K, Niemann M, Drylewicz J, van Zuilen AD, Joosten I, Allebes WA, van der Meer A, Hilbrands LB, Baas MC, Hack CE, van Reekum FE, Verhaar MC, Kamburova EG, Bots ML, Seelen MAJ, Sanders JS, Hepkema BG, Lambeck AJ, Bungener LB, Roozendaal C, Tilanus MGJ, Vanderlocht J, Voorter CE, Wieten L, van Duijnhoven EM, Gelens M, Christiaans MHL, van Ittersum FJ, Nurmohamed A, Lardy JNM, Swelsen W, van der Pant KA, van der Weerd NC, Ten Berge IJM, Bemelman FJ, Hoitsma A, van der Boog PJM, de Fijter JW, Betjes MGH, Heidt S, Roelen DL, Claas FH, Otten HG, Spierings E.

Front Immunol. 2018 Mar 5;9:321. doi: 10.3389/fimmu.2018.00321. eCollection 2018.

18.

Elevated intragraft expression of innate immunity and cell death-related markers is a risk factor for adverse graft outcome.

Yang J, Snijders MLH, Haasnoot GW, van Kooten C, Mallat M, de Fijter JW, Clahsen-van Groningen MC, Claas FHJ, Eikmans M.

Transpl Immunol. 2018 Jun;48:39-46. doi: 10.1016/j.trim.2018.02.009. Epub 2018 Feb 20.

PMID:
29475090
19.

Differential effects of donor-specific HLA antibodies in living versus deceased donor transplant.

Kamburova EG, Wisse BW, Joosten I, Allebes WA, van der Meer A, Hilbrands LB, Baas MC, Spierings E, Hack CE, van Reekum FE, van Zuilen AD, Verhaar MC, Bots ML, Drop ACAD, Plaisier L, Seelen MAJ, Sanders JSF, Hepkema BG, Lambeck AJA, Bungener LB, Roozendaal C, Tilanus MGJ, Voorter CE, Wieten L, van Duijnhoven EM, Gelens M, Christiaans MHL, van Ittersum FJ, Nurmohamed SA, Lardy NM, Swelsen W, van der Pant KA, van der Weerd NC, Ten Berge IJM, Bemelman FJ, Hoitsma A, van der Boog PJM, de Fijter JW, Betjes MGH, Heidt S, Roelen DL, Claas FH, Otten HG.

Am J Transplant. 2018 Sep;18(9):2274-2284. doi: 10.1111/ajt.14709. Epub 2018 Apr 16.

20.

Predicition models for delayed graft function: external validation on The Dutch Prospective Renal Transplantation Registry.

Kers J, Peters-Sengers H, Heemskerk MBA, Berger SP, Betjes MGH, van Zuilen AD, Hilbrands LB, de Fijter JW, Nurmohamed AS, Christiaans MH, Homan van der Heide JJ, Debray TPA, Bemelman FJ.

Nephrol Dial Transplant. 2018 Jul 1;33(7):1259-1268. doi: 10.1093/ndt/gfy019.

PMID:
29462353

Supplemental Content

Loading ...
Support Center